Obesity represents health, social and economic threat for most of countries worldwide. Bariatric surgery of obesity is the most effective long-term treatment modality for patients suffering from higher degrees of obesity.
The aim was to use new technologies for treating obesity and preventing diabetes: gastric balloon and laparoscopic bandage of gastric.
We examined 508 obesity patients (379 females and 129 males) aged 19.9 to 78.5 years. The mean age was 48.5±29.5 years. BMI varied from 30.2 to 60.1 kg/m2. In 68 patients with BMI 30.0 - 40.0 kg / m2 was used gastric balloon for 6 months. We used laparoscopic bandage of gastric (Obtech Medical AG) in 54 patients with BMI more than 40.0 kg/m2.
Obesity-related comorbidities were revealed in 92.3% of patients: arterial hypertension – 87.6%; back pain – 79.9%; type 2 diabetes – 31.1%; osteoarthritis – 26.9%; reflux esophagitis – 24.5%; dysmenorrhea – 23.4%; sleep apnoe – 19.1%. Weight loss after use of gastric balloon was from 23 to 38 kg (mean 30.5±15.2 kg), max after 6 months. Complications were revealed in 6 (8.8%) patients. Weight loss in patients after laparoscopic bandage of gastric was from 23 to 58 kg (mean 40.5±16.7 kg). After 1 year BMI was normal in 32.7% this patients. Complications were revealed in 4 patients. Glycaemia, cholesterol, triglycerides significantly decreased in two groups.
New technologies for treating obesity, gastric balloon and laparoscopic bandage of gastric, have positive effects on weight loss, preventing diabetes and improving of obesity-related comorbidities.